Studies available for: Gastroenterology

See a study that interests you? Contact that study's coordinator for more information on how to participate.


Study Information:
PHASE I SAFETY AND TOLERABILITY OF L. REUTERI IN HEALTHY ADULTS
Houston, TX
UT Houston
This study will evaluate the safety and tolerability of the probiotic Lactobacillus reuteri (LR) in healthy adult patients. Patients will be randomized to receive either LR or placebo orally each day for a total of 60 doses. The effects on fecal bacteria, circulating white blood cell receptors and inflammatory cytokine profiles will be measured.
HSC-MS-08-0266
NIH
Subject Information:
18 - 60
Inclusion Criteria: Healthy Adults (18 - 60 years old) No other recognized illness Exclusion Criteria: Pregnancy or breastfeeding Patient taking immunosuppressive medications, including oral corticosteroids Positive result of HIV, Hepatitis B, and/or Hepatitis C test Abnormal lab test results Gastrointestinal related diseases and surgeries Patients with an allergy to antibiotics Presence of fever or a pre-existing adverse event monitored in the study No more than two study participants in one household Use of probiotics in the last 90 days Diarrheal illness within the past 30 days Recent or current use of oral antibiotics /anti-fungals(in the past 2 weeks) Current use of oral laxatives Chronic alcohol use o
Study Coordinator(s) Information:
Nicole Fatheree
nicole.fatheree@uth.tmc.edu
713-500-5669
Principal Investigator Information:
J. Marc Rhoads, M.D.